Psychiatric Effects and Psychoactive Substance Use in Anabolic-Androgenic Steroid Users
| Autor: | D. A. Malone, J. A. Lombardo, R. H B Sample, Robert J. Dimeff |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
Adult
Male medicine.medical_specialty Bipolar Disorder Alcohol Drinking Personality Inventory Weight Lifting Substance-Related Disorders Population Physical Therapy Sports Therapy and Rehabilitation Anabolic Agents Psychiatric history Humans Medicine Orthopedics and Sports Medicine Psychological testing Medical history Medical History Taking education Psychiatry Depression (differential diagnoses) Depressive Disorder Psychotropic Drugs education.field_of_study business.industry Mental Disorders Discontinuation Hypomania Androgens Female medicine.symptom Personality Assessment Inventory business |
| Zdroj: | Clinical Journal of Sport Medicine. 5:25-31 |
| ISSN: | 1050-642X |
| DOI: | 10.1097/00042752-199501000-00005 |
| Popis: | The purpose of this study was to assess the psychiatric effects of anabolic-androgenic steroid (AAS) use and assess the frequency of other psychoactive substance use in a population of AAS users compared with non-AAS-using weight-lifter controls. One hundred sixty-four subjects were administered a demographic survey, including psychiatric history, substance use history, AAS use history, and medical history. Psychiatric diagnoses were made and psychological testing was performed. User categories were determined by history and urine testing. The user categories did not differ significantly on psychological testing. Past AAS users had a higher incidence of psychiatric diagnosis than the nonuser and current user groups. Hypomania was correlated with AAS use, and major depression with AAS discontinuation. Present psychoactive substance abuse or dependence was relatively low across all user categories. AAS dependence was seen in 12.9% of current users and 15.2% of past users of AAS. In conclusion, AAS use may lead to psychiatric disorders in certain individuals. Concurrent use of psychoactive drugs other than AAS does not appear to be common in intensively training weight lifters and bodybuilders. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|